Drug Profile
eTS 1166
Alternative Names: eTS-1166Latest Information Update: 03 Oct 2015
Price :
$50
*
At a glance
- Originator e-Therapeutics
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Methicillin-resistant Staphylococcus aureus infections
Most Recent Events
- 19 Jan 2007 Phase-II clinical trials in Meticillin-resistant Staphylococcus aureus infections in United Kingdom (unspecified route)